title: Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial.
authors.affiliation: Department of Radiotherapy, Gustave Roussy, Villejuif, France; Kremlin-Bicêtre Medical Faculty, Paris-Sud University, France; INSERM 1030 Molecular Radiotherapy, France.
authors.forename: Antonin
authors.initials: A
authors.lastname: Levy
authors.affiliation: Department of Radiotherapy, Institut régional du Cancer de Montpellier (ICM) - Val d'Aurelle, Montpellier, France.
authors.forename: David
authors.initials: D
authors.lastname: Azria
authors.affiliation: Department of Biostatistics, Gustave Roussy, Villejuif, France.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Pignon
authors.affiliation: Department of Radiotherapy, Institut Curie, Paris, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Delarochefordiere
authors.affiliation: Department of Radiotherapy, Centre Léon Bérard, Lyon, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Martel-Lafay
authors.affiliation: Department of Radiotherapy, Institut de Cancérologie de l'Ouest, Saint Herblain, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Rio
authors.affiliation: Department of Medical Oncology, Gustave Roussy, Villejuif, France.
authors.forename: David
authors.initials: D
authors.lastname: Malka
authors.affiliation: Unicancer, Paris, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Conroy
authors.affiliation: Department of Radiotherapy, Saint Gregoire, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Miglianico
authors.affiliation: Department of Radiotherapy, Institut Bergonié, Bordeaux, France.
authors.forename: Yves
authors.initials: Y
authors.lastname: Becouarn
authors.affiliation: Department of Biostatistics, Gustave Roussy, Villejuif, France.
authors.forename: Katty
authors.initials: K
authors.lastname: Malekzadeh
authors.affiliation: Department of Biostatistics, Gustave Roussy, Villejuif, France.
authors.forename: Julie
authors.initials: J
authors.lastname: Leclercq
authors.affiliation: Unicancer, Paris, France.
authors.forename: Beata
authors.initials: B
authors.lastname: Juzyna
authors.affiliation: Department of Radiotherapy, Gustave Roussy, Villejuif, France.
authors.forename: Patrick
authors.initials: P
authors.lastname: Ezra
authors.affiliation: Department of Radiotherapy, Institut régional du Cancer de Montpellier (ICM) - Val d'Aurelle, Montpellier, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Lemanski
authors.affiliation: Department of Radiotherapy, Gustave Roussy, Villejuif, France; Kremlin-Bicêtre Medical Faculty, Paris-Sud University, France; INSERM 1030 Molecular Radiotherapy, France. Electronic address: eric.deutsch@gustaveroussy.fr.
authors.forename: Eric
authors.initials: E
authors.lastname: Deutsch
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000532:radiotherapy*; D000068818:Cetuximab; D059248:Chemoradiotherapy; D017322:Clinical Trials, Phase II as Topic; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab